Clinical Distribution and Drug Resistance of Methicillin-Resistant Staphylococcus Aureus Infection of Newborns
Objective To analyze clinical distribution and drug resistance of methicillin-resistant Staphylococcus aureus infection of newborns.Methods The paper chose 80 newborns with methicillin-resistant Staphylococcus aureus(MRSA)infection in our hospital from January 2020 to January 2023 as research subjects,analyzed clinical distribution and drug resistance of MRSA infection.Results Among distribution of 80 cases MRSA,specimen types showed,there were 47 cases(58.75%)of sputum and 11 cases(13.75%)of pus,10 cases of wound secretions(12.50%),7 cases of blood(8.75%),and 5 cases of urine(6.25%).Resistance rate of MRSA to penicillin G was the highest(100%),followed by erythromycin(76.25%),clindamycin(68.75%),tetracycline(48.75%),oxacillin(46.20%),and compound sulfamethoxazole(11.50%).Resistance rate to other drugs was below 10.00%.Conclusion Neonatal methicillin-resistant Staphylococcus aureus(MRSA)infection can achieve high incidence in different specimen types,especially in sputum,and exhibit high resistance to multiple antibiotics.It is necessary to strengthen monitoring for high-risk departments and different specimen types,and highlight importance of rational use of antibiotics.
万方数据
维普
